CERT: Rasio silihan jangka dawa marang modal certara.com

Certara, Inc. (CERT) develops AI tools for virtual drug testing, replacing routine experiments with digital models. Business stability is underpinned by leadership in biomodeling, while long-term debt, as reflected in the asset value chart, is fixed at 0.32. However, global conflicts and data localization requirements are forcing a revision of storage infrastructure, which negatively impacts the profitability of overseas operations.

This ratio is critical for stress-testing debt load and assessing the issuer's financial stability. It measures the proportion of credit obligations with a maturity exceeding one year relative to equity, which on the long-term debt-to-equity chart for Certara, Inc. (CERT) in GURU.Markets reflects the financing strategy of Certara, Inc. (CERT), whose dominant position in biosimulation and status as an FDA standard enable efficient management of borrowed capital.